CGC
$1.23
$-0.06
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes. It offers its products under the Tweed, 7ACRES, 7ACRES Craft Collective, DOJA, Ace Valley, Quatreau, Deep Space, First + Free, Surity Pro, Spectrum Therapeutics, Vert, Tokyo Smoke, Twd, Martha Stewart CBD, DNA Genetics, BioSteel, Storz & Bickel, This Works, HiWay, Simple Stash, Whisl, and Truverra brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.
Next Earnings
2026-01-11
Beta
2.147
Average Volume
31841069
Market Cap
294933500
Last Dividend
0
CIK
0001737927
ISIN
CA1380357048
CUSIP
138035100
CEO
Luc Mongeau
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Full Time Employees
1029
IPO Date
2014-04-07
Status
Active
Latest News
| Title | Headline | Publisher | Date |
|---|---|---|---|
| Canopy Growth Corporation (CGC) Stock Dips While Market Gains: Key Facts | In the latest trading session, Canopy Growth Corporation (CGC) closed at $1.23, marking a -4.65% move from the previous day. | Zacks Investment Research | 2026-01-09 19:01:04 |
| Marijuana industry taking fight against Wall Street blockades straight to Trump | Bankers have argued that Pot Inc.'s far-bigger prospective business – recreational use that would include the smoking of joints and ingesting high-inducing gummies – wasn't specifically addressed by the president's edict. | New York Post | 2026-01-09 07:00:00 |
| Canopy Growth Corporation (CGC) is Attracting Investor Attention: Here is What You Should Know | Zacks.com users have recently been watching Canopy Growth (CGC) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects. | Zacks Investment Research | 2026-01-08 10:00:35 |
| Canopy Growth Announces Strategic Recapitalization Transactions Significantly Strengthening Balance Sheet to Support Growth Strategy | SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, announced today that the Company has entered into a series of transactions to recapitalize its balance sheet and extend the maturity dates of all outstanding indebtedness to January 2031 at the earliest. At the conclusion of these Transactions (as defined below), Canopy Gro. | Business Wire | 2026-01-08 07:00:00 |
| Canopy Growth Corporation (NASDAQ:CGC) Given Consensus Recommendation of “Reduce” by Brokerages | Shares of Canopy Growth Corporation (NASDAQ: CGC - Get Free Report) have received a consensus rating of "Reduce" from the five analysts that are covering the stock, MarketBeat.com reports. Two equities research analysts have rated the stock with a sell rating and three have assigned a hold rating to the company. A number of equities analysts | Defense World | 2026-01-02 01:08:48 |
| First Look: 2026 Outlook, Buffett Exit, Fed Split, Dollar Slide | Stock News Street sets 2026 expectations: Wall Street sees the S&P 500 posting modest-to-mid-teens gains in 2026 after a 16.39% rise in 2025, with AI leaders li | GuruFocus | 2026-01-01 07:37:00 |
| Canopy Growth Corporation (CGC) Suffers a Larger Drop Than the General Market: Key Insights | In the latest trading session, Canopy Growth Corporation (CGC) closed at $1.16, marking a -4.13% move from the previous day. | Zacks Investment Research | 2025-12-30 18:50:36 |
| The 2026 Cannabis Wildcard: How Tax Reform Could Reset Stock Valuations | On Dec. 18, 2025, President Trump signed a pivotal Executive Order directing the Attorney General to expedite the rescheduling of cannabis. By all traditional metrics, this political victory should have sparked a sustained rally. | MarketBeat | 2025-12-30 15:28:33 |
| Do These 2 Cannabis Stocks Have a Future? | Recent regulatory developments have improved the landscape of the cannabis industry in the U.S. Canopy Growth and Aurora Cannabis are two leaders in the Canadian market that could turn their attention here. Even with this recent progress, though, neither stock has attractive prospects. | The Motley Fool | 2025-12-28 23:09:00 |
| 2 Marijuana Stocks To Watch For Better Investing In 2026 | The cannabis industry continues evolving into a bigger and more regulated global market. Legalization trends are expanding across the United States and international regions. This growth fuels long-term opportunities for marijuana stock investors and those looking to get invested in the industry. Cannabis stocks benefit from increasing consumer demand and acceptance. Medical cannabis adoption supports consistent revenue and defensive market positioning. | MarijuanaStocks | 2025-12-28 13:05:59 |
| I Was Right: President Trump Will Legalize Marijuana in 2026 | President Trump has ordered that marijuana be reclassified as a Schedule III drug. The move doesn't fully legalize marijuana -- yet -- but it may foreshadow changes to come. | The Motley Fool | 2025-12-28 09:00:00 |
| 3 Marijuana Stocks To Watch In 2026 | The cannabis industry is entering another critical growth phase, positioning 2026 as a potentially pivotal year. Particularly for long-term investors looking to make a profit with marijuana stocks. After years of regulatory uncertainty, capital constraints, and volatile price action, relief is being shown. The legal cannabis market is showing clear signs of structural improvement driven by policy reform, consolidation, and expanding global demand. | MarijuanaStocks | 2025-12-26 13:58:51 |
| Marijuana Stocks To Watch After The Holidays | In 2026, the impact of cannabis rescheduling is expected to be far more visible in marijuana stock performance. Much more than in the initial announcement of cannabis becoming a Class 3 substance. While 2025 seemed to be a transition year, 2026 could mark another pivot point. Specifically, one where improved business operations begin to consistently translate into stronger equity valuations across the sector. Investor sentiment may also shift meaningfully. | MarijuanaStocks | 2025-12-24 11:52:28 |
| The "New Vice" Economy: 5 Stocks Profiting from the Shift to Clean Fuel | VANCOUVER, British Columbia, Dec. 24, 2025 (GLOBE NEWSWIRE) -- USA News Group - News Commentary - American consumers are driving record wellness spending as they abandon traditional cigarettes and sugary energy drinks for cleaner, more precise alternatives[1]. The shift is accelerating across functional beverage categories, where protein, adaptogens, and targeted nutrition now dominate new product launches[2]. | Globe News Wire | 2025-12-24 06:00:00 |
| 3 Top Marijuana Stocks After Cannabis Gets Rescheduled | Donald Trump's recent executive order moving cannabis off Schedule I marks a pivotal moment for the U.S. cannabis sector. While the order does not legalize marijuana at the federal level, rescheduling fundamentally changes how the plant is viewed under federal law. With meaningful implications for operators, investors, and public markets. For the cannabis industry, the most immediate impact is financial. A shift to Schedule III would effectively eradicate IRS Section 280E. This is a law that currently prevents cannabis businesses from deducting standard operating expenses. | MarijuanaStocks | 2025-12-22 11:35:56 |
| Benzinga Bulls And Bears: Carnival, Caterpillar, Meta — And Markets Make Modest Gains | Benzinga examined the prospects for many investors' favorite stocks over the last week - here's a look at some of our top stories. | Benzinga | 2025-12-20 08:31:05 |
| 3 Best Cannabis Stocks: Will They Fly High Again Post Trump Schedule III? | Cannabis stocks sold off this week following President Trump's Executive Order directing marijuana's reclassification to Schedule III for increased medical and cannabidiol research. The sharp selloff highlights how fragile sentiment in cannabis stock remains, even amid policy progress. Further volatility is possible if regulatory implementation drags on or if broader market risk appetite weakens. | Seeking Alpha | 2025-12-19 18:52:28 |
| Inside the dealmaking that pushed Trump to reclassify pot, expand access | President Donald Trump's marijuana reclassification executive order followed a yearlong push by cannabis executives, billionaire allies and political operatives combining donations, lobbying and targeted polling, according to industry insiders. Trulieve CEO Kim Rivers and Palm Beach billionaire Howard Kessler leveraged personal ties, fundraisers and political spending to press the White House, according to multiple insiders, including one CEO of a cannabis company listed on the New York Stock Exchange, who requested anonymity to speak candidly. | CNBC | 2025-12-19 17:20:41 |
| Trump signs executive order to reschedule cannabis. Here's what's next | Trump's executive order shifts cannabis from Schedule I to Schedule III, and launches a Medicare pilot program for CBD products. Brandon Gomez unpacks what's next, the hurdles ahead and what shifted the President's stance on the drug. | CNBC Television | 2025-12-19 11:49:20 |
| Trump just legalized marijuana nationwide — here's why potheads are rejoicing | As On The Money has been reporting since April, our famously drug-and-drink-averse president has been inching ever closer to making marijuana significantly less criminal in the eyes of the federal government. | New York Post | 2025-12-19 09:44:18 |
| Trump Orders Marijuana Reclassification: What It Means for the Sector | Trump's executive order to move marijuana to Schedule III could reshape cannabis regulation and taxes, lifting sentiment around cannabis stocks. | Zacks Investment Research | 2025-12-19 09:32:13 |
| Trump sparks market shock with MAJOR marijuana move | Rep. Greg Steube, R-Fla., joins ‘Mornings with Maria' to discuss cutting healthcare costs, the fight over Obamacare subsidies and shutdown risks, President Donald Trump's marijuana order and the GOP's push to sell unused federal buildings. | Fox Business | 2025-12-19 09:00:43 |
| Former WH drug policy advisor: Mass commercialization and promotion of marijuana isn't a good thing | Kevin Sabet, Smart Approaches to Marijuana CEO, former White House drug policy advisor and ‘One Nation Under Influence' author, joins 'Squawk Box' to discuss President Trump's executive order to reclassify marijuana from a Schedule 1 to a Schedule 3 drug, the dangers of today's marijuana, impact on the broader legalization process, and more. | CNBC Television | 2025-12-19 07:53:53 |
| Down 99% in 5 Years, Is It Finally Time to Buy This Stock? | Canopy Growth's latest quarter was decent, with the company making progress on the bottom line. Some investors are hoping that positive regulatory developments in the U.S. could be a turning point. | The Motley Fool | 2025-12-19 07:45:00 |
| Cannabis companies face hurdles accessing big banks despite reclassification, experts say | U.S. President Donald Trump's move to relax marijuana regulations could ease some burden for cannabis companies, but will likely keep doors to access capital from big banks closed, experts said. | Reuters | 2025-12-18 19:14:16 |
| Trulieve CEO Kim Rivers reacts to marijuana being reclassified | Trulieve Founder, Chair, and CEO Kim Rivers joins 'Fast Money' with reaction to Pres. Trump reclassifying marijuana. | CNBC Television | 2025-12-18 18:09:30 |
| Trump signed an executive order to reclassify marijuana. | About Yahoo Finance: Yahoo Finance provides free stock ticker data, up-to-date news, portfolio management resources, comprehensive market data, advanced tools, and more information to help you manage your financial life. - Get the latest news and data at finance.yahoo.com - Download the Yahoo Finance app on Apple (https://apple.co/3Rten0R) or Android (https://bit.ly/3t8UnXO) - Follow Yahoo Finance on social: X: http://twitter.com/YahooFinance Instagram: https://www.instagram.com/yahoofinance/?hl=en TikTok: https://www.tiktok.com/@yahoofinance?lang=en Facebook: https://www.facebook.com/yahoofinance/ LinkedIn: https://www.linkedin.com/company/yahoo-finance | Yahoo Finance | 2025-12-18 17:30:13 |
| Trump signs executive order to reschedule marijuana, expand access to CBD products | President Donald Trump on Thursday signed an executive order directing the federal government to move marijuana from Schedule I to Schedule III, potentially easing regulatory and financial constraints for cannabis companies while keeping recreational use illegal under federal law. The order instructs the attorney general to expedite the ongoing process of rescheduling marijuana, which is currently classified alongside heroin and LSD as a Schedule I drug — considered to have a high potential for abuse and no accepted medical use. | Proactive Investors | 2025-12-18 15:34:21 |
| Donald Trump Has Officially Reclassified Marijuana To A Schedule 3 Substance | It has officially happened, Donald J Trump has signed the executive order to reschedule cannabis. Now, cannabis has been taken from a Class 1 to a Class 3 substance under the Controlled Substances. At this time, there is more to come in terms of what will take place specifically for legal operators and the cannabis industry overall. This push for reform has been ongoing for over a decade, and now the time has finally arrived. Some basic info that this law will do is allow the IRS to work with legal cannabis businesses. This will be done by giving them tax breaks and incentives. | MarijuanaStocks | 2025-12-18 15:25:47 |
| Trump signs executive order on marijuana reclassification; cannabis shares rally | President Donald Trump signed an executive order on Thursday directing federal agencies to reclassify marijuana from Schedule I to Schedule III. The move sent US cannabis stocks sharply higher on expectations of lighter regulation and expanded medical research. | Invezz | 2025-12-18 14:49:29 |
| President Trump signs executive order to reclassify marijuana, easing federal restrictions | President Trump signs an executive order to reclassify marijuana to a Schedule III classification, easing federal restrictions. | CNBC Television | 2025-12-18 14:31:31 |
| Trump Signs Order Easing Federal Restrictions on Marijuana | President Donald Trump signs an executive order directing his administration to move cannabis into a less restrictive federal category. Sign up for the Washington Edition newsletter to find out how the worlds of money and politics intersect in the US capital: https://bloom.bg/3KkEimO -------- More on Bloomberg Television and Markets Like this video? | Bloomberg Markets and Finance | 2025-12-18 14:29:39 |
| Trump signs executive order easing federal restrictions on marijuana | Trump signed an executive order that will reclassify marijuana as a less harmful drug. The order is aimed at making it easier to research the drug. | Business Insider | 2025-12-18 14:06:03 |
| Trump signs executive order reclassifying pot, opening door to broader access | President Donald Trump signed an executive order Thursday reclassifying marijuana as a Schedule III substance with looser restrictions. | CNBC | 2025-12-18 14:05:23 |
| Trump moves to ease cannabis restrictions - what does it mean for consumers? | U.S. President Donald Trump said he will direct the U.S. Department of Justice to reclassify cannabis as a less dangerous drug. Here's a look at what that would mean for people shopping at dispensaries across the country. | Reuters | 2025-12-18 14:04:58 |
| Trump moving to ease US marijuana regulations, sparking industry hopes | U.S. President Donald Trump on Thursday said he would sign an order recommending the loosening of federal regulations on marijuana, a move that could further reverse decades of tough-on-weed policy. | Reuters | 2025-12-18 13:51:31 |
| Tilray and Cannabis Stocks Soar Ahead of Expected Trump Executive Order on Marijuana | Shares of Tilray Brands and other cannabis stocks are rising ahead of President Donald Trump's executive order signing ceremony. | Barrons | 2025-12-18 10:10:00 |
| Explainer: What will change if the US reclassifies marijuana? | U.S. President Donald Trump is expected to sign an executive order that would reclassify marijuana and ease federal restrictions on research that could lead to new medical marijuana products. Here is what you need to know: | Reuters | 2025-12-17 18:28:54 |
| Pot stocks pop on Schedule 3 hopes: Tilray Brands, Trulieve Cannabis, Cresco Labs: How high will they go? | Shares of publicly traded companies operating in the cannabis space continue to perform strongly as the Trump administration considers reclassifying marijuana. | Fast Company | 2025-12-17 13:31:37 |
| Trump expected to sign executive order to fast-track reclassification of cannabis, NBC News reports | U.S. President Donald Trump is expected to sign an executive order as soon as this week that would fast-track the reclassification of cannabis, NBC News reported on Tuesday, citing four people with direct knowledge of the plans. | Reuters | 2025-12-16 19:16:01 |
| Canopy Growth to acquire MTL Cannabis, expanding Québec presence | Canopy Growth Corporation (TSX:WEED, NYSE:CGC) announced that it has agreed to acquire MTL Cannabis (CSE:MTLC) in a transaction valued at approximately C$125 million on a fully diluted equity basis and about C$179 million on an enterprise value basis. Under the terms of a definitive arrangement agreement, Canopy Growth will acquire all issued and outstanding shares of MTL Cannabis and settle the target's outstanding debt and debt-like instruments. | Proactive Investors | 2025-12-16 15:10:24 |
| Canopy Growth to acquire MTL Cannabis, expanding Québec presence | Canopy Growth Corporation (TSX:WEED, NYSE:CGC) announced that it has agreed to acquire MTL Cannabis (CSE:MTLC) in a transaction valued at approximately... | Proactive Investors - Finance | 2025-12-16 10:07:00 |
| Best Canadian Cannabis Stocks to Watch This Week for Traders and Investors | Canadian cannabis stocks remain in focus this week as sector sentiment continues improving. Several Canadian operators maintain meaningful exposure to the U.S. market through brands and partnerships. Meanwhile, the U.S. cannabis industry continues expanding despite regulatory delays. Total U.S. cannabis sales now exceed $32 billion annually. Importantly, analysts project the market could surpass $50 billion by 2030. That growth outlook keeps Canadian operators relevant for global investors. Recently, renewed federal reform discussions returned to headlines. Cannabis rescheduling remains under active government review. Additionally, lawmakers continue debating banking access and tax reform measures. While timing remains uncertain, momentum has improved compared to prior years. As a result, Canadian cannabis stocks often react sharply to U.S. policy developments. Therefore, investors are watching these names closely for near-term momentum and long-term positioning. | MarijuanaStocks | 2025-12-16 10:00:28 |
| Trump again says he is considering reclassifying marijuana as less dangerous drug | President Donald Trump said he is considering an executive order to reclassify marijuana as Schedule III drug, citing research benefits and public demand for policy reform. | Fox Business | 2025-12-15 21:55:47 |
| Canopy Growth Corporation (CGC) Suffers a Larger Drop Than the General Market: Key Insights | Canopy Growth Corporation (CGC) concluded the recent trading session at $1.66, signifying a -4.6% move from its prior day's close. | Zacks Investment Research | 2025-12-15 18:51:07 |
| Trump Weighs Marijuana Changes: 'A Lot Of People Want To See It' | President Donald Trump told reporters on Monday he is weighing an executive order to reclassify marijuana as a Schedule III substance. | Benzinga | 2025-12-15 18:18:53 |
| Market Today: Ford axes Lightning, iRobot bankrupt, Nvidia-China chips | Stock News Ford pivots from full EV to hybrids and storage: Ford Motor (F) will discontinue the allâelectric Fâ150 Lightning and replace it with a plugâin | GuruFocus | 2025-12-15 17:36:00 |
| Trump says he's 'strongly' considering reclassifying pot via executive order | President Donald Trump confirmed he's considering an executive order loosening regulations on marijuana. Pot stocks fell on Monday as investors took profits following a record-setting session. | CNBC | 2025-12-15 16:28:44 |
| Dow Jones Today: Stocks Slip to Begin Week; AI-Tied Shares Continue to Weigh on Nasdaq | Major stock indexes finished lower to begin the last full trading week of the year, with AI-tied shares again weighing on the Nasdaq. | Investopedia | 2025-12-15 16:06:20 |
| Trump says he is considering executive order to reclassify marijuana | President Donald Trump said on Monday he is considering signing an executive order to reclassify marijuana as a less dangerous drug. | Reuters | 2025-12-15 15:53:14 |
| The Rally for Cannabis Stocks Grinds to a Halt Amid Uncertainty About Trump Order | Weed stocks aren't flying so high anymore. | Investopedia | 2025-12-15 14:35:36 |
| Stock Market Live December 15: S&P 500 (SPY) Could Test 7,600 in 2026 | Live Updates JPMorgan Just Listed its Top Internet Stocks for 2026 3 hours ago Live JPMorgan is betting that tech will have another big year ahead, noting that the AI theme will continue to be a key catalyst. On the list is Alphabet, which the firm says could rally to $385, thanks in part to... Stock Market Live December 15: S&P 500 (SPY) Could Test 7,600 in 2026. | 247 Wallst | 2025-12-15 08:37:33 |
| Canopy Growth to Acquire MTL Cannabis; Transaction Expected to Create Canada's Leading Medical Cannabis Business and Enhance Capacity to Serve Growing International Demand | SMITHS FALLS, Ontario & POINTE-CLAIRE, Quebec--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC) and MTL Cannabis Corp. (“MTL Cannabis” or “MTL”) (CSE: MTLC) (OTCQX: MTLNF) are pleased to announce that they have entered into a definitive arrangement agreement (the “Arrangement Agreement”) pursuant to which Canopy Growth will acquire all of the issued and outstanding common shares of MTL (the “MTL Shares”) and will settle all debt and debt-li. | Business Wire | 2025-12-15 07:00:00 |
| Canopy Growth Sees Unusually High Options Volume (NASDAQ:CGC) | Canopy Growth Corporation (NASDAQ: CGC - Get Free Report) was the recipient of unusually large options trading activity on Friday. Investors acquired 43,864 call options on the company. This represents an increase of 77% compared to the typical volume of 24,748 call options. Canopy Growth Price Performance NASDAQ CGC opened at $1.74 on Friday. The company | Defense World | 2025-12-13 01:14:45 |
| Cannabis stocks spike on reports Trump plans to ease federal pot restrictions | The rally marked one of the biggest single-day moves for cannabis stocks in years, snapping a prolonged slump. | New York Post | 2025-12-12 16:21:30 |
| Cannabis stocks surge on Trump's rumored Schedule 3 marijuana change. How high can pot shares get? | Multiple news reports this week said that President Trump is expected to reclassify marijuana's drug scheduling, which would lessen restrictions on its use and potentially allow companies that operate in the cannabis space to increase business. | Fast Company | 2025-12-12 16:11:04 |
| Trump Expected to Label Pot a Less Dangerous Drug | President Donald Trump is expected have his administration classify marijuana as a less dangerous drug, according to people familiar with the matter. This has been good news for pot stocks. | Bloomberg Markets and Finance | 2025-12-12 14:21:24 |
| Trump Lights Up the Cannabis Market With Plans for Reclassification | Trump plans to sign an executive order directing federal agencies to reclassify marijuana from Schedule I to Schedule III. Reclassification could boost after-tax profits by 40% to 70% for U.S. cannabis operators by ending the 280E tax penalty. | 24/7 Wall Street | 2025-12-12 13:52:58 |
| Marijuana Stocks Are Soaring Friday on Anticipation Trump Could Soon Make This Change | Cannabis stocks surged Friday following reports President Donald Trump could soon reclassify marijuana as a less dangerous substance. | Investopedia | 2025-12-12 13:40:37 |
| Why Canopy Growth Stock Popped Today | President Trump may start the process of legalizing weed on Monday. First step: Rescheduling the drug as "Schedule III. | The Motley Fool | 2025-12-12 13:03:32 |
| Trump expected to sign executive order to reclassify marijuana as soon as Monday, source tells CNBC | Cannabis stocks jumped Friday as the White House moved to significantly ease federal restrictions on marijuana. Brandon Gomez has the latest on the timing of a potential Executive Order and why the industry says it's “more optimistic” this time around. | CNBC Television | 2025-12-12 11:52:41 |
| Stock Market Live December 12, 2025: S&P 500 (SPY) Slumping with Tech Stocks Tumble | Live Updates Goldman Sachs Sets a 7,600 Target on S&P 500 for 2026 59 minutes ago As we wrap up 2025, analysts at Goldman Sachs say 2026 could be stronger. In fact, the firm just set a target of 7,600 for the S&P 500, believing that artificial intelligence will be a key catalyst. "The process... Stock Market Live December 12, 2025: S&P 500 (SPY) Slumping with Tech Stocks Tumble. | 247 Wallst | 2025-12-12 09:34:45 |
| Stock Market Live December 12: Trump to Ease Marijuana Regulation, S&P 500 (VOO) Flat | Live Updates Johnson Outdoors Taken to Woodshed 58 minutes ago Live Camping- and fishing-goods supplier Johnson Outdoors (Nasdaq: JOUT) missed earnings by a massive $2.15 this morning, reporting a fiscal Q4 2025 loss of $2.83 per share. This was despite beating revenue estimates with sales of $135.8 million. Losses did improve year over year (meaning Johnson... Stock Market Live December 12: Trump to Ease Marijuana Regulation, S&P 500 (VOO) Flat. | 247 Wallst | 2025-12-12 09:24:17 |
| Tilray and Canopy Growth Stocks Surge on Reports Trump to Loosen Marijuana Restrictions | The reclassification of the drug would alleviate tax burdens on cannabis companies. | Barrons | 2025-12-12 08:59:00 |
| Cannabis stocks surge as Trump signals shift on US marijuana policy | US-listed cannabis stocks saw sharp premarket gains on Friday after fresh reporting pointed to a possible change in federal marijuana policy under President Donald Trump. The development revived investor focus on regulatory risk, funding constraints, and the industry's long-stalled growth prospects. | Invezz | 2025-12-12 07:15:23 |
| Canopy Growth stock is pumping today: will these gains hold? | Canopy Growth stock price staged a strong comeback in the pre-market session as investors cheered the latest news on cannabis rescheduling. CGC jumped by over 35% to $1.530, pushing its market cap to over $400 million. | Invezz | 2025-12-12 04:23:51 |
| Canopy Growth Corporation (CGC) Is a Trending Stock: Facts to Know Before Betting on It | Recently, Zacks.com users have been paying close attention to Canopy Growth (CGC). This makes it worthwhile to examine what the stock has in store. | Zacks Investment Research | 2025-12-11 10:01:23 |
| Canopy Growth Launches Claybourne Gassers Liquid Diamonds All-In-One Vapes in Canada, Expanding Footprint in High-Growth Vape Segment | SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, today announced the national launch of Claybourne Gassers, a new lineup of All-in-One (AIO) vapes featuring liquid diamonds. The launch marks Claybourne's entry into Canada's vape category, building on its leadership in high potency infused products. The Claybourne Gassers. | Business Wire | 2025-12-04 07:00:00 |
| Canadian Cannabis Market Outlook for December 2025: Key Trends for Investors | The Canadian cannabis sector enters December 2025 with renewed attention from both traders and long-term investors. Market conditions have remained unpredictable this year, yet several leading companies continue showing resilience and strategic progress. The industry still faces slower domestic growth, tighter financing conditions, and heavy price competition. However, many operators are building stronger platforms, expanding international footprints, and positioning themselves for potential U.S. policy shifts. As these developments unfold, Canadian cannabis stocks remain essential watchlist candidates heading into the new year. | MarijuanaStocks | 2025-12-02 10:00:15 |
| Canadian Gold Corp. Tartan Mine "Western Flank" Step-Out Drilling Continues to Deliver | Flin Flon, Manitoba--(Newsfile Corp. - November 27, 2025) - Canadian Gold Corp. (TSXV: CGC) ("Canadian Gold" or the "Company") is pleased to announce ongoing results from its Phase 4 drill program at the 100%-owned Tartan Mine, near Flin Flon, Manitoba. Encouraging results, especially along the Main Zone's Western Flank, continue to support the plan to move toward a potential mine restart. | Newsfile Corp | 2025-11-27 07:00:00 |
| 'Green Wednesday': A high holiday for cannabis before Thanksgiving | Cannabis has carved out it's own holiday shopping rush and it's called "Green Wednesday". Behind April 20, the day before Thanksgiving has become the second-biggest day for cannabis sales in the U.S. Brandon Gomez unpacks the new buzzy trend for an age old tradition. | CNBC Television | 2025-11-26 12:19:12 |
| Investors Heavily Search Canopy Growth Corporation (CGC): Here is What You Need to Know | Canopy Growth (CGC) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock. | Zacks Investment Research | 2025-11-26 10:01:24 |
| Three Canadian Cannabis Stocks Worth Watching This Week | The U.S. legal cannabis industry is showing strong momentum, and the time may be ripe to scan for promising Canadian-listed stocks. In fact, the U.S. market is projected to reach about US$45 billion in 2025, growing at roughly an 11-12 percent annual rate through the rest of the decade. Meanwhile, public support for reform sits near record levels, and recent headlines highlighted renewed federal attention on descheduling efforts. These developments increased optimism, although uncertainty remains. Consequently, Canadian cannabis companies with U.S. exposure could benefit significantly if policy improves. At the same time, traders should not overlook technical analysis. Reviewing chart patterns, volume behavior, and trend strength can help identify reasonable entries. Furthermore, proper risk management remains essential. Using stop-losses, controlling position size, and avoiding emotional decisions can protect capital in a volatile sector. Thus, identifying the right Canadian cannabis stocks to watch this week becomes increasingly important. | MarijuanaStocks | 2025-11-18 10:00:18 |
| Canopy Growth Expands Spectrum Therapeutics Portfolio in Australia with New Softgels | SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, has expanded its Spectrum Therapeutics portfolio in Australia with the availability of new softgel capsules, further enhancing the Company's medical cannabis offerings in the region. The formats include Spectrum Yellow Cannabis Oil Softgels (CBD 20mg), Spectrum Red Cannabis. | Business Wire | 2025-11-18 07:00:00 |
| Investing in Cannabis: Three Leading Stocks to Watch This November | The U.S. cannabis market continues to evolve as new legislative discussions, consumer trends, and business developments shape the industry's momentum. Although volatility remains, investors are increasingly watching leading cannabis companies for signs of stabilization and long-term growth potential. November 2025 brings a renewed focus on recognizable names that continue to push toward profitability, expand product lines, and position themselves for future U.S. federal reform. Meanwhile, market participants continue to closely monitor price action, utilizing technical analysis and disciplined risk management to identify strong investment opportunities. Support and resistance levels remain important as cannabis stocks often experience sharp swings. Therefore, traders must stay patient and selective when approaching the sector. Despite short-term uncertainty, several companies remain compelling due to their strong brands, diversified strategies, and ongoing operational improvements. Below are three top marijuana stocks to watch this month. | MarijuanaStocks | 2025-11-15 10:00:01 |
| Should You Buy, Hold or Sell CGC Stock Post Q2 Earnings Release? | Canopy Growth's narrower loss, rising Canadian sales and improving margins signal progress in its turnaround, even as competition and global headwinds persist. | Zacks Investment Research | 2025-11-13 10:01:52 |
| Cannabis Investing Insight: Here Is How To Invest In Marijuana Stocks | Marijuana Stock investors are keeping a close eye on new market opportunities. With constant shifts in the cannabis industry, forecasting more accurate trading is challenging. The way most pot stocks trade is similar to others in the regard that if one company goes up, others may as well. It is the speculation of what may occur in the grey area industry. Legal operators that make up the industry fight to prove to the public the importance and legitimacy of legal cannabis. | MarijuanaStocks | 2025-11-12 11:34:03 |
| Here is What to Know Beyond Why Canopy Growth Corporation (CGC) is a Trending Stock | Canopy Growth (CGC) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock. | Zacks Investment Research | 2025-11-12 10:01:17 |
| Canopy Growth Q2 Results - Improved Net Loss, But Risks Remain | Canopy Growth reported improved financial results for Q2, with higher revenue and improved net loss. CGC saw an increase in sales of Canadian cannabis, while international cannabis decreased YoY. The stock price is down 68% over the last year. | Seeking Alpha | 2025-11-12 09:00:00 |
| Canopy Growth Corporation (WEED:CA) Q2 2026 Earnings Call Transcript | Canopy Growth Corporation ( WEED:CA ) Q2 2026 Earnings Call November 7, 2025 10:00 AM EST Company Participants Tyler Burns - Director of Investor Relations Luc Mongeau - CEO & Director Thomas Stewart - Chief Accounting Officer & CFO Conference Call Participants William Kirk - ROTH Capital Partners, LLC, Research Division Aaron Grey - Alliance Global Partners, Research Division Frederico Yokota Gomes - ATB Capital Markets Inc., Research Division Pablo Zuanic - Zuanic & Associates Presentation Operator Good morning. My name is Joanna, and I will be your conference operator today. | Seeking Alpha | 2025-11-07 12:36:12 |
| The Jobs Week That Wasn't, Plus More Q3 Earnings | For employment numbers, we can cobble together what we have, and try to construct something that resembles a realistic labor market scenario. | Zacks Investment Research | 2025-11-07 11:30:20 |
| Canopy Growth Corporation (CGC) Reports Q2 Loss, Misses Revenue Estimates | Canopy Growth Corporation (CGC) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to a loss of $0.95 per share a year ago. | Zacks Investment Research | 2025-11-07 09:20:50 |
| Canopy Growth Reports Second Quarter Fiscal 2026 Financial Results; Company Continues to Strengthen Financial Performance with Improving Adjusted EBITDA, Disciplined Cost Management, and a Stronger Balance Sheet | SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (Nasdaq: CGC) today announced its financial results for the second quarter ended September 30, 2025 ("Q2 FY2026"). All financial information in this press release is reported in Canadian dollars, unless otherwise indicated. “We're building a stronger, more competitive company defined by continued momentum in Canada adult-use cannabis, consistent growth in Canada medical cannabis, and. | Business Wire | 2025-11-07 07:00:00 |
| 'Trump effect' raises hopes for cannabis rally as investors bet on federal reforms, softer marijuana stance | Cannabis stocks could rally on hopes for new hemp regulations and Trump's possible softer stance on marijuana, fueling investor optimism across the industry. | CNBC | 2025-11-01 08:00:01 |
| Canopy Growth Corporation (CGC) Suffers a Larger Drop Than the General Market: Key Insights | In the most recent trading session, Canopy Growth Corporation (CGC) closed at $1.22, indicating a -2.4% shift from the previous trading day. | Zacks Investment Research | 2025-10-30 18:50:20 |
| Top Growth Stocks To Follow Now – October 28th | Prologis, Teledyne Technologies, Ascendis Pharma A/S, Hamilton Lane, Acadia Realty Trust, Canopy Growth, and Hercules Capital are the seven Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are shares of companies expected to grow their revenue and earnings significantly faster than the overall market, often reinvesting profits into expansion rather | Defense World | 2025-10-30 02:10:24 |
| Top Cannabis Stocks To Follow Now – October 28th | Tilray Brands, Canopy Growth, and SNDL are the three Cannabis stocks to watch today, according to MarketBeat's stock screener tool. Cannabis stocks are shares of publicly traded companies involved in the legal cannabis industry, including growers, processors, retailers, biotech firms developing cannabinoid-based medicines, and ancillary service or equipment providers. For investors, these stocks typically carry | Defense World | 2025-10-30 02:09:56 |
| Global Computing Consortium Hosts CGC 2025, Unveiling Over 20 Breakthrough Achievements and Industry Standards | SHENZHEN, China, Oct. 30, 2025 (GLOBE NEWSWIRE) -- The 2025 Global Computing Conference (CGC 2025), hosted by the Global Computing Consortium (GCC), will take place on November 7–8, 2025, at the Shenzhen Convention and Exhibition Center (Futian) under the theme “Building New Foundations, Powering NewIntelligence-Embracing the Al Future” The event will focus on trend insights, technology solutions, resource alignment, and scenario implementation—accelerating innovation across the intelligent computing ecosystem. | GlobeNewsWire | 2025-10-30 00:51:00 |
| Is Trending Stock Canopy Growth Corporation (CGC) a Buy Now? | Canopy Growth (CGC) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects. | Zacks Investment Research | 2025-10-29 10:01:34 |
| Top Cannabis Stocks To Add to Your Watchlist – October 24th | Tilray Brands, Canopy Growth, and Greenlane are the three Cannabis stocks to watch today, according to MarketBeat's stock screener tool. Cannabis stocks are shares of publicly traded companies whose core businesses are tied to the cannabis plant and its products, including growers, processors, distributors, retailers, and ancillary firms (e.g., biotech, equipment, or software providers serving | Defense World | 2025-10-26 02:39:36 |
| Growth Stocks To Follow Now – October 24th | Prologis, Ascendis Pharma A/S, Teledyne Technologies, Pattern Group, and Canopy Growth are the five Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are shares of companies expected to grow revenue and earnings at a faster rate than the overall market, often reinvesting profits into expansion instead of paying dividends. Investors | Defense World | 2025-10-26 02:39:35 |
| Canopy Growth to Report Second Quarter Fiscal 2026 Financial Results on November 7, 2025 | SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX:WEED, NASDAQ:CGC) will release its financial results for the second quarter fiscal year 2026 ended September 30, 2025 before financial markets open on November 7, 2025. Following the release of its second quarter fiscal year 2026 financial results, Canopy Growth will host an audio webcast with Luc Mongeau, CEO and Tom Stewart, CFO on November 7, 2025 at 10 AM Eastern Time (ET). Webcast Info. | Business Wire | 2025-10-24 07:00:00 |
| Canadian Cannabis Leaders Poised for Growth as U.S. Legalization Momentum Builds | The Canadian cannabis sector continues to attract attention as investors look for opportunities amid renewed optimism surrounding U.S. legalization. The U.S. cannabis industry is projected to exceed $40 billion in annual sales by 2026, reflecting steady growth despite regulatory delays. Recent headlines about federal rescheduling discussions and state-level legalization measures have reignited momentum across both Canadian and American operators. As a result, Canadian producers like Tilray, Canopy Growth, and Village Farms are once again in focus. These companies remain well-positioned to benefit from any U.S. reform that opens cross-border trade or new investment flows. Moreover, strong consumer demand, expanding export markets, and cost-efficient production models continue to drive long-term growth potential across the sector. | MarijuanaStocks | 2025-10-23 10:00:49 |
| Canopy Growth Corporation (CGC) Stock Dips While Market Gains: Key Facts | In the latest trading session, Canopy Growth Corporation (CGC) closed at $1.31, marking a -2.96% move from the previous day. | Zacks Investment Research | 2025-10-17 18:51:23 |
| Canopy Growth Corporation (CGC) Falls More Steeply Than Broader Market: What Investors Need to Know | Canopy Growth Corporation (CGC) closed the most recent trading day at $1.35, moving 7.53% from the previous trading session. | Zacks Investment Research | 2025-10-16 19:01:11 |
| Is Most-Watched Stock Canopy Growth Corporation (CGC) Worth Betting on Now? | Zacks.com users have recently been watching Canopy Growth (CGC) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects. | Zacks Investment Research | 2025-10-15 10:01:20 |
| Canopy Growth Announces Results of Annual General and Special Meeting of Shareholders | SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, is pleased to announce today the voting results from its Annual General and Special Meeting of Shareholders convened on September 26, 2025 and adjourned to, and reconvened on, October 10, 2025 (the “Meeting”). All of the matters put forward before the Company's shareholders. | Business Wire | 2025-10-14 07:00:00 |
SEC Filings
| Type | Filing Date | Accepted Date | Link |
|---|---|---|---|
| S-3 | 2026-01-09 | 2026-01-09 | View Filing |
| 8-K | 2026-01-08 | 2026-01-08 | View Filing |
| 4 | 2026-01-02 | 2026-01-02 | View Filing |
| 4 | 2026-01-02 | 2026-01-02 | View Filing |
| 8-K | 2025-12-15 | 2025-12-15 | View Filing |
| 4 | 2025-11-13 | 2025-11-13 | View Filing |
| 8-K | 2025-11-07 | 2025-11-07 | View Filing |
| 10-Q | 2025-11-07 | 2025-11-07 | View Filing |
| 3 | 2025-10-14 | 2025-10-14 | View Filing |
| 8-K | 2025-10-14 | 2025-10-14 | View Filing |
| 4 | 2025-09-30 | 2025-09-30 | View Filing |
| 4 | 2025-09-30 | 2025-09-30 | View Filing |
| 4 | 2025-09-30 | 2025-09-30 | View Filing |
| 4 | 2025-09-30 | 2025-09-30 | View Filing |
| DEFA14A | 2025-09-26 | 2025-09-26 | View Filing |
| DEFA14A | 2025-09-24 | 2025-09-24 | View Filing |
| 4 | 2025-09-23 | 2025-09-23 | View Filing |
| 4 | 2025-09-19 | 2025-09-19 | View Filing |
| DEFA14A | 2025-09-19 | 2025-09-19 | View Filing |
| 8-K | 2025-09-17 | 2025-09-17 | View Filing |
| DEFA14A | 2025-09-03 | 2025-09-03 | View Filing |
| 8-K | 2025-08-29 | 2025-08-29 | View Filing |
| 424B5 | 2025-08-29 | 2025-08-29 | View Filing |
| 4 | 2025-08-26 | 2025-08-26 | View Filing |
| 4 | 2025-08-26 | 2025-08-26 | View Filing |
| 4 | 2025-08-20 | 2025-08-20 | View Filing |
| DEFA14A | 2025-08-19 | 2025-08-19 | View Filing |
| DEFA14A | 2025-08-19 | 2025-08-19 | View Filing |
| DEFA14A | 2025-08-15 | 2025-08-15 | View Filing |
| 4 | 2025-08-14 | 2025-08-14 | View Filing |
| 3 | 2025-08-08 | 2025-08-08 | View Filing |
| 8-K | 2025-08-08 | 2025-08-08 | View Filing |
| 10-Q | 2025-08-08 | 2025-08-08 | View Filing |
| DEFA14A | 2025-08-07 | 2025-08-07 | View Filing |
| ARS | 2025-08-07 | 2025-08-07 | View Filing |
| DEF 14A | 2025-08-07 | 2025-08-07 | View Filing |
| 8-K | 2025-07-29 | 2025-07-29 | View Filing |
| PRE 14A | 2025-07-25 | 2025-07-25 | View Filing |
| 3 | 2025-07-11 | 2025-07-11 | View Filing |
| 8-K | 2025-07-09 | 2025-07-09 | View Filing |
| 4 | 2025-07-02 | 2025-07-02 | View Filing |
| 4 | 2025-07-02 | 2025-07-02 | View Filing |
| 4 | 2025-07-02 | 2025-07-02 | View Filing |
| 4 | 2025-06-17 | 2025-06-17 | View Filing |
| 4 | 2025-06-17 | 2025-06-17 | View Filing |
| 424B7 | 2025-06-06 | 2025-06-06 | View Filing |
| 424B5 | 2025-06-06 | 2025-06-06 | View Filing |
| 4 | 2025-06-05 | 2025-06-05 | View Filing |
| 4 | 2025-06-05 | 2025-06-05 | View Filing |
| 4 | 2025-06-05 | 2025-06-05 | View Filing |
| 4 | 2025-06-05 | 2025-06-05 | View Filing |
| 4 | 2025-06-05 | 2025-06-05 | View Filing |
| 4 | 2025-06-05 | 2025-06-05 | View Filing |
| EFFECT | 2025-06-05 | 2025-06-05 | View Filing |
| POS AM | 2025-05-30 | 2025-05-30 | View Filing |
| 8-K | 2025-05-30 | 2025-05-30 | View Filing |
| 10-K | 2025-05-30 | 2025-05-30 | View Filing |
| POSASR | 2025-05-29 | 2025-05-29 | View Filing |
| SD | 2025-05-21 | 2025-05-21 | View Filing |
| 4 | 2025-04-02 | 2025-04-02 | View Filing |
| 4 | 2025-04-02 | 2025-04-02 | View Filing |
| 4 | 2025-04-02 | 2025-04-02 | View Filing |
| 8-K | 2025-04-01 | 2025-04-01 | View Filing |
| 8-K | 2025-02-28 | 2025-02-28 | View Filing |
| 424B5 | 2025-02-28 | 2025-02-28 | View Filing |
| 4 | 2025-02-13 | 2025-02-13 | View Filing |
| 8-K | 2025-02-07 | 2025-02-07 | View Filing |
| 10-Q | 2025-02-07 | 2025-02-07 | View Filing |
| 4 | 2025-01-03 | 2025-01-03 | View Filing |
| 4 | 2025-01-03 | 2025-01-03 | View Filing |
| 4 | 2025-01-03 | 2025-01-03 | View Filing |
| 4 | 2025-01-03 | 2025-01-03 | View Filing |
| 8-K | 2024-12-10 | 2024-12-10 | View Filing |
| 424B7 | 2024-12-10 | 2024-12-10 | View Filing |
| 8-K | 2024-12-09 | 2024-12-09 | View Filing |
| 8-K | 2024-11-26 | 2024-11-26 | View Filing |
| 8-K | 2024-11-08 | 2024-11-08 | View Filing |
| 10-Q | 2024-11-08 | 2024-11-08 | View Filing |
| 8-K | 2024-10-17 | 2024-10-17 | View Filing |
| 4 | 2024-10-02 | 2024-10-02 | View Filing |
| 4 | 2024-10-02 | 2024-10-02 | View Filing |
| 4 | 2024-10-02 | 2024-10-02 | View Filing |
| 4 | 2024-10-02 | 2024-10-02 | View Filing |
| 8-K | 2024-09-25 | 2024-09-25 | View Filing |
| DEFA14A | 2024-09-23 | 2024-09-20 | View Filing |
| DEFA14A | 2024-09-16 | 2024-09-16 | View Filing |
| DEFA14A | 2024-09-13 | 2024-09-13 | View Filing |
| DEFA14A | 2024-09-11 | 2024-09-11 | View Filing |
| 4 | 2024-08-26 | 2024-08-26 | View Filing |
| 4 | 2024-08-26 | 2024-08-26 | View Filing |
| 4 | 2024-08-26 | 2024-08-26 | View Filing |
| DEFA14A | 2024-08-23 | 2024-08-23 | View Filing |
| 8-K | 2024-08-23 | 2024-08-23 | View Filing |
| DEFA14A | 2024-08-16 | 2024-08-16 | View Filing |
| 8-K | 2024-08-16 | 2024-08-16 | View Filing |
| DEFA14A | 2024-08-13 | 2024-08-13 | View Filing |
| DEFA14A | 2024-08-13 | 2024-08-13 | View Filing |
| 8-K | 2024-08-09 | 2024-08-09 | View Filing |
| 10-Q | 2024-08-09 | 2024-08-09 | View Filing |
| DEFA14A | 2024-08-01 | 2024-08-01 | View Filing |
Algorithm Performance
| Algorithm | Profit/Loss | Profit Factor | # Trades | Sharpe | Sortino | Efficiency |
|---|---|---|---|---|---|---|
| Quantum Inspired Strategy | 66.40% | 1 | 555 | 0.03 | 0.07 | 39.58 |
| Volatility Squeeze | 43.63% | 0.98 | 29 | 0.03 | 0.11 | 16.81 |
| Genetic Strat | 42.48% | 1 | 1065 | 0.02 | 0.05 | 15.66 |
| xxxxxxxxxxxxx | xxxxxxx% | xxxx | x | xxxx | xxxx | xxxxx |
| xxxxxxxxxxxxxxxxxxxxx | xxxxxxx% | xxxx | x | xxxx | xxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxx% | xxxx | xxx | xxxx | xxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxx% | xxxx | xxx | xxxx | xxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxxx | xxxxxxx% | xxxx | xxx | xxxx | xxxx | xxxx |
| xxxxxxxxxx | xxxxxxx% | xxxx | xxxx | xxxx | xxxx | xxxxx |
| xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxx% | xxxx | xxxx | xxxx | xxxx | x |
| xxxxxxxxx | xxxxxxx% | x | xxxx | xxxx | xxxx | xxxx |
| xxxxxxxxxxxxxxxx | xxxxx% | xxxx | xxx | xxxx | xxxx | xxx |
| xxxxxxxxxxxxxxxxxxxxxxx | xxxxx% | xxxx | xxx | xxxx | xxxx | xxxx |
| xxx | xxxxxxx% | x | xxx | xxxx | xxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxx% | x | xxx | xxxx | xxxx | xxxxx |
| xxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxx% | xxxx | xx | xxxx | xxxx | xxxxx |
| xxxxxxxxxxxxxxxxx | xxxxxxx% | xxxx | xx | xxxx | xxxx | xxxxx |
| xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxx% | xxxx | xxx | xxxx | xxxx | xxxxx |
| xxxxxxxxx | xxxxxxx% | xxxx | xxx | xxxx | xxxx | xxxxx |
| xxxxxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxx% | xxxx | xx | xxxx | xxxx | xxxxx |
| xxxxxxxxxxxxxxxxxxxxxxxxxxx | xxxxx% | x | xxx | x | xxxx | xxxxx |
| xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxx% | xxxx | xx | xxxx | xxxx | xxxxx |
| xxxxxxxxxxxxxxxxxxxxxxxxxxx | xxxxxx% | x | xxxx | x | xxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxx | xxxxxxx% | x | xxxx | x | xxxx | xxxxx |
| xxxxxxxxx | xxxxxxx% | xxxx | xxx | x | xxxx | xxxxx |
| xxxxxxxxxxxxxx | xxxxxxx% | x | xxxx | x | xxxx | xxxxx |
| xxxxxxxxxxxxxxxxxxxxxxx | xxxxxxx% | x | xxx | x | xxxx | xxxxx |
| xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx | xxxxxx% | x | xxx | x | xxxx | xxxxx |
| xxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxxx% | x | xxx | xxxxx | x | xxxxx |
| xxxxxxxxxxxx | xxxxxxxx% | x | xxx | x | x | xxxxx |
| xxxxxxxxxx | xxxxxxxx% | x | xxxx | xxxxx | x | xxxxx |
| xxxxxxxxxxxxxxxxxxxxxxx | xxxxxxx% | xxxx | xxx | xxxxx | xxxxx | xxxxx |
| xxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxxx% | x | xxx | xxxxx | xxxxx | xxxxx |
| xxxx | xxxxxxxx% | x | xxxx | xxxxx | xxxxx | xxxxx |
| xxxxxxxxxxxxxxxxxxxxxx | xxxxxxxx% | x | xxxx | xxxxx | xxxxx | xxxxx |
| xxxxxxxxxxxxxxx | xxxxxxxx% | xxxx | xx | xxxxx | xxxxx | xxxxx |
| xxxxxxxxxxxxxxxxxxxxx | xxxxxxxx% | xxxx | xxx | xxxxx | xxxxx | xxxxx |
| xxxx | xxxxxxxx% | x | xxxx | xxxxx | xxxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxxx% | x | xxx | xxxxx | xxxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxx | xxxxxxxx% | xxxx | xxx | xxxxx | xxxxx | xxxxx |
| xxxxxxxxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxxx% | xxxx | xxx | xxxxx | xxxxx | xxxxx |
| xxxxxxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxxx% | x | xxxx | xxxxx | xxxxx | xxxxx |